Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic mice.
The toxicity of amyloid β and tau, the two hallmark proteins in Alzheimer's disease (AD), has been extensively studied individually. Recently new data suggest their possible interactions and synergistic effects in the disease. In this study, we investigate the ability of antibodies against the...
Saved in:
| Main Authors: | Inna Rabinovich-Nikitin, Idan S Rakover, Maria Becker, Beka Solomon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0046650&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Presenilin-1 Familial Alzheimer Mutations Impair γ-Secretase Cleavage of APP Through Stabilized Enzyme–Substrate Complex Formation
by: Sujan Devkota, et al.
Published: (2025-07-01) -
Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer’s Disease
by: Tatjana L. Rothhaar, et al.
Published: (2012-01-01) -
A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
by: April M Weissmiller, et al.
Published: (2015-01-01) -
Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
by: Hermien Acx, et al.
Published: (2017-06-01) -
The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease
by: Gao Ning, et al.
Published: (2025-08-01)